These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 29701806)

  • 1. High fibroblast growth factor 23 is associated with coronary calcification in patients with high adiponectin: analysis from the KoreaN cohort study for Outcome in patients With Chronic Kidney Disease (KNOW-CKD) study.
    Hyun YY; Kim H; Oh YK; Oh KH; Ahn C; Sung SA; Choi KH; Kim SW; Lee KB
    Nephrol Dial Transplant; 2019 Jan; 34(1):123-129. PubMed ID: 29701806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone biomarkers help grading severity of coronary calcifications in non dialysis chronic kidney disease patients.
    Morena M; Jaussent I; Halkovich A; Dupuy AM; Bargnoux AS; Chenine L; Leray-Moragues H; Klouche K; Vernhet H; Canaud B; Cristol JP
    PLoS One; 2012; 7(5):e36175. PubMed ID: 22567137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High estimated glomerular filtration rate is associated with coronary artery calcification in middle-aged Korean men without chronic kidney disease.
    Choi HM; Hyun YY; Lee KB; Kim H
    Nephrol Dial Transplant; 2015 Jun; 30(6):996-1001. PubMed ID: 25994662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arterial Stiffness as a Risk Factor for Subclinical Coronary Artery Calcification in Predialysis Chronic Kidney Disease: From the KNOW-CKD Study.
    Hyun YY; Kim H; Oh KH; Ahn C; Park SK; Chae DW; Han SH; Kim YS; Lee SW; Kim CS; Lee KB
    Kidney Blood Press Res; 2019; 44(3):426-434. PubMed ID: 31132783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FGF-23 and the progression of coronary arterial calcification in patients new to dialysis.
    Khan AM; Chirinos JA; Litt H; Yang W; Rosas SE
    Clin J Am Soc Nephrol; 2012 Dec; 7(12):2017-22. PubMed ID: 22997345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of serum 25-hydroxyvitamin D3, fibroblast growth factor-23, and C1q/tumor necrosis factor-related protein-3 with coronary artery calcification in nondialysis chronic kidney disease patients.
    Zhu Y; Hu Z; Liu Y; Qin C; Chen X; Shi Y; Wang L
    Ren Fail; 2023 Dec; 45(1):2220412. PubMed ID: 37293793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphate, fibroblast growth factor 23 and retinopathy in chronic kidney disease: the Chronic Renal Insufficiency Cohort Study.
    Mehta R; Ying GS; Houston S; Isakova T; Nessel L; Ojo A; Go A; Lash J; Kusek J; Grunwald J; Wolf M;
    Nephrol Dial Transplant; 2015 Sep; 30(9):1534-41. PubMed ID: 25910495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast growth factor 23 predicts coronary calcification and poor prognosis in patients with chronic kidney disease stages 3-5D.
    Zhang M; Yan J; Zhu M; Ni Z
    Ann Clin Lab Sci; 2015; 45(1):17-22. PubMed ID: 25696005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of fractional phosphate excretion on the relation of FGF23 with outcome in CKD patients.
    Bech AP; Bouma-de Krijger A; van Zuilen AD; Bots ML; van den Brand JA; Blankestijn PJ; Wetzels JF; Vervloet MG
    J Nephrol; 2015 Aug; 28(4):477-84. PubMed ID: 25700931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of epicardial fat with coronary calcification, insulin resistance, inflammation, and fibroblast growth factor-23 in stage 3-5 chronic kidney disease.
    Kerr JD; Holden RM; Morton AR; Nolan RL; Hopman WM; Pruss CM; Garland JS
    BMC Nephrol; 2013 Jan; 14():26. PubMed ID: 23351146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender Specific Association between Serum Fibroblast Growth Factor 23/α-Klotho and Coronary Artery and Aortic Valve Calcification.
    Morita H; Takeda Y; Fujita S; Okamoto Y; Sakane K; Teramoto K; Ozeki M; Tasaki R; Kizawa S; Sohmiya K; Hoshiga M; Ishizaka N
    J Atheroscler Thromb; 2015; 22(12):1338-46. PubMed ID: 26279337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast growth factor 23 is associated with carotid artery calcification in chronic kidney disease patients not undergoing dialysis: a cross-sectional study.
    Nakayama M; Kaizu Y; Nagata M; Ura Y; Ikeda H; Shimamoto S; Kuma K
    BMC Nephrol; 2013 Jan; 14():22. PubMed ID: 23339433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FGF-23 levels are associated with vascular calcification, but not with atherosclerosis, in hemodialysis patients.
    Turan MN; Kircelli F; Yaprak M; Sisman AR; Gungor O; Bayraktaroglu S; Ozkahya M; Asci G; Floege J; Ok E
    Int Urol Nephrol; 2016 Apr; 48(4):609-17. PubMed ID: 26865177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast growth factor 23 and new-onset chronic kidney disease in the general population: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study.
    De Jong MA; Eisenga MF; van Ballegooijen AJ; Beulens JWJ; Vervloet MG; Navis G; Gansevoort RT; Bakker SJL; De Borst MH
    Nephrol Dial Transplant; 2021 Jan; 36(1):121-128. PubMed ID: 32124925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of coronary artery calcification with renal function decline and mortality in predialysis chronic kidney disease patients.
    Lamarche MC; Hopman WM; Garland JS; White CA; Holden RM
    Nephrol Dial Transplant; 2019 Oct; 34(10):1715-1722. PubMed ID: 30010904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of lanthanum carbonate on coronary artery calcification and bone mineral density in maintenance hemodialysis patients with diabetes complicated with adynamic bone disease: A prospective pilot study.
    Zhang C; Wang S; Zhao S; Zhang X
    Medicine (Baltimore); 2017 Nov; 96(45):e8664. PubMed ID: 29137107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of fibroblast growth factor-23 with markers of inflammation, insulin resistance and obesity in adults.
    Hanks LJ; Casazza K; Judd SE; Jenny NS; Gutiérrez OM
    PLoS One; 2015; 10(3):e0122885. PubMed ID: 25811862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic Kidney Disease-Mineral Bone Disorder in Korean Patients: a Report from the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD).
    Kim CS; Bae EH; Ma SK; Han SH; Lee KB; Lee J; Oh KH; Chae DW; Kim SW;
    J Korean Med Sci; 2017 Feb; 32(2):240-248. PubMed ID: 28049234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary artery calcification, ADMA, and insulin resistance in CKD patients.
    Kobayashi S; Oka M; Maesato K; Ikee R; Mano T; Hidekazu M; Ohtake T
    Clin J Am Soc Nephrol; 2008 Sep; 3(5):1289-95. PubMed ID: 18562597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast growth factor 23 is not associated with and does not induce arterial calcification.
    Scialla JJ; Lau WL; Reilly MP; Isakova T; Yang HY; Crouthamel MH; Chavkin NW; Rahman M; Wahl P; Amaral AP; Hamano T; Master SR; Nessel L; Chai B; Xie D; Kallem RR; Chen J; Lash JP; Kusek JW; Budoff MJ; Giachelli CM; Wolf M;
    Kidney Int; 2013 Jun; 83(6):1159-68. PubMed ID: 23389416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.